S

SCP Vitalife

50 employees

SCP Vitalife Partners is a venture capital firm focused on life science investments in Israel and the U.S.

Investor insights

Sectors invested in

Health Care14
Medical Device12
Biotechnology6
Pharmaceutical6
Medical4
Pharmaceuticals3
Ophthalmics3
medical devices2
Cerner1
non-invasive system for monitoring and management of lung fluid in patients with heart failure1
ReDS - Easy to use1
Health Diagnostics1
Artificial Intelligence1
Analytics1
Robotics1
Machine Learning1
colorectal surgery1
surgical devices1
colon cancer treatment1
GI disease management1

Funding rounds participated in

$14M sweet spot round size

Most of their 14 investments are in rounds between $10M and $25M

Investor type

Venture Capital

Basic info

Sectors

Medical Device
Pharmaceutical
Life Science

Date founded

2002

Investments made

-

- raised $15M on February 7, 2016

Investors: Medica Venture Partners, T3 and SCP Vitalife

I

Ivenix, Inc. raised $42M on September 1, 2015

Investors: Easterly Capital, Cardinal Partners (CP), F-Prime Capital Partners and SCP Vitalife

M

MST - Medical Surgery Technologies raised $13M on July 1, 2015

Investors: Triventures, OurCrowd, Jacobs, Agate Medical Investments Group and SCP Vitalife

S

Sensible Medical Innovations raised $20M on November 11, 2013

Investors: Genesis Partners and SCP Vitalife

G

Glaukos Corneal Health raised $43M on March 5, 2013

Investors: Echelon Ventures, Aperture Venture Partners, Abingworth, Prism Venture Partners, Flagship Ventures, Borealis Ventures, Western Technology and SCP Vitalife

-

- raised $10M on May 14, 2012

Investors: DSM Venturing and SCP Vitalife

G

Glaukos Corneal Health raised $500K on February 21, 2012

Investors: SCP Vitalife

U

Undisclosed raised $25M on August 16, 2011

Investors: F-Prime Capital Partners, Easterly Capital, -, Cardinal Partners (CP) and SCP Vitalife

G

Glaukos Corneal Health raised $25M on July 7, 2011

Investors: Aperture Venture Partners and SCP Vitalife

N

NiTi Surgical Solutions raised $19M on August 11, 2009

Investors: Evergreen venture partners, Cipio Partners, Forbion, Israel HealthCare Ventures (IHCV) and SCP Vitalife

FAQ